An economist reports that the cost data from Medicare are “completely irrelevant. It is clearly measures of net costs that matter, but only gross costs (analogous to sticker prices) are provided. Similar issues arise with recent requirements for hospital price transparency.”

Dale Lehman writes: I’ve been trying to understand the large changes being made to Medicare Part D drug plan coverage and prices. Due to recent changes, Part D actually looks more like an insurance plan than it used to – … Continue reading → …